|
TEAM
 Our investment team has over 60 years of collective experience in operating and investing in leading cleantech, medical, and technology companies. We have established a reputation for selecting highly promising young companies, nurturing their development, expanding their network and financing sources, and building successful businesses.
Birchmere Ventures has invested in dozens of early stage companies, resulting in numerous IPOs and M&A transactions since 1996. Our partners have worked together for a decade applying their industry experience and expertise in engineering, operations, strategic planning, marketing, and capital markets to our portfolio companies.
Bay City Capital, represented by Jeanne Cunicelli, partnered with us to provide life sciences investing and operating resources to a special purpose investment vehicle. Gary Glausser is also a partner in that fund.
|
